S.Biomedics에스바이오메딕스
304360 · KOSDAQ · ₩304360 · 에스바이오메딕스
₩20,150▼ ₩50 (0.25%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Gross margin | 49.3% | 45.6% | 48.8% | 50.0% |
| Operating margin | −68.4% | −50.4% | −39.6% | −45.7% |
| Net margin | −73.1% | −49.1% | −42.4% | −57.4% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue growth | −0.3% | +20.5% | +4.8% | — |
| Operating income growth | −35.2% | −53.2% | +9.1% | — |
| Net income growth | −48.5% | −39.5% | +22.6% | — |
Returns
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Return on equity | −61.8% | −79.1% | −61.9% | −108.5% |
| Return on assets | −11.5% | −16.5% | −15.2% | −20.2% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Liabilities to equity | 92.3% | 146.4% | 143.6% | 160.3% |
| Net debt to equity | −45.2% | 41.8% | 72.6% | 79.5% |
| Current ratio | 655.7% | 161.0% | 248.7% | 203.1% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: S.Biomedics / 에스바이오메딕스 / 304360 / KRX:304360
Source: KRX statistical information